Navigation Links
Cumberland Pharmaceuticals to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
Date:5/11/2011

NASHVILLE, Tenn., May 11, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the 2011 UBS Global Specialty Pharmaceuticals Conference in London on Wednesday, May 25, 2011, at 12:30 p.m.

The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations section of Cumberland Pharmaceuticals' website at www.cumberlandpharma.com.

Shortly following the live webcast a replay will also be available on the Company's website.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® for the treatment of acetaminophen poisoning, Caldolor®, the first injectable treatment for pain and fever approved in the United States, and Kristalose®, a prescription laxative. Cumberland is dedicated to providing innovative products which improve quality of care for patients. For more information, please visit the Company website at www.cumberlandpharma.com.


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
2. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
3. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
4. Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting
5. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
6. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
7. Cumberland Pharmaceuticals to Announce 2010 Financial Results on March 8, 2011
8. Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote
9. Cumberland Pharmaceuticals Announces Joey Jacobs Has Joined Its Board of Directors
10. Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
11. Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...   Cepheid (Nasdaq: CPHD ) today announced ... second quarter ended June 30, 2015 on Thursday, July ... The Company will host a management presentation at ... to discuss the results.  To access the live webcast, ... least 15 minutes before the scheduled start time to ...
(Date:7/6/2015)... , July 6, 2015 Akcea Therapeutics, ... ISIS ), announced today that the U.S. ... Designation to volanesorsen (ISIS-APOCIII Rx ) for the ... FCS is a rare genetic disease characterized by ... In a Phase 2 study published in the ...
(Date:7/6/2015)... SHENZHEN, China , July 6, 2015 China ... CNIT), a leading provider of integrated cloud-based platform, exchange, ... , today announced that the Company launched its mobile ... age of accessible healthcare services on mobile devices. The ... District Health and Family Planning Bureau and Shenzhen News ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... DIEGO, Dec. 9 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... Brian M. Culley, will present to investors as part of ... 15, 2009 at 9:30 a.m. Eastern time. , Interested parties ... www.informedinvestors.com , a link to which is available on ...
... , WALTHAM, Mass., ... research and advisory firms focusing on pharmaceutical and healthcare issues, ... claims data, TNF-alpha inhibitors are being used more often to ... as many newly diagnosed second-line patients received a TNF-alpha inhibitor ...
Cached Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3
(Date:7/6/2015)... Georgia (PRWEB) , ... July 06, 2015 , ... ... has received nearly $400,000 in grant funds to support a three-year effort to ... , The work will be conducted in partnership with the Morehouse School of ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took ... Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody fusion on ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... ... ancillary benefits market, is excited to announce the next generation of PrimeStar Individual ... Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and usual, ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student ... 2 months of unlimited classes for just $65. Student ID is needed at registration. ... Road in Lake Orion. , Women’s Excellence is the most comprehensive ...
(Date:7/4/2015)... ... , ... Chronic Neck Pain. Neck pain is no small problem. ... neck. Another 19% suffer from head, migraine, or facial pain, in some cases related ... American workers must deal with neck pain. Strategies for mitigating neck pain ...
Breaking Medicine News(10 mins):Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3
... A new study finds that people with prediabetes are no ... small fiber polyneuropathy than healthy people, a finding that contradicts ... said the results from their five-year study of 550 people ... in patients with painful small fiber polyneuropathy. Prediabetes, also ...
... , FRIDAY, Feb. 24 (HealthDay News) --,New ... predict age-related macular degeneration, one of the leading causes ... (AMD) were especially likely to have an overexpression of ... University of California Santa Barbara (UCSB), the University of ...
... in tumors., Invasion and metastasis were blocked by inhibition ... late-stage clinical trials. PHILADELPHIA Dual inhibition ... tumor invasion and metastasis in a laboratory model of ... Cancer Discovery , the newest journal of the ...
... Voluminous research literature attests to the multiple negative ... health and development of children. In contrast, there is ... fathers according to a follow up study by NYU ... edition of Maternal and Child Health Journal. ...
... features such as behavior, coat color and susceptibility to ... possible genetic cause for differential gene expression and biological ... pieces of mobile DNA that exist in the genome ... mice, according to a new study led by researchers ...
... , THURSDAY, Feb. 23 (HealthDay News) -- Noninvasive, ... its ability to detect colorectal cancer and precancerous polyps ... Virtual colonoscopy, also called CT colonography, uses virtual-reality ... and rectum. While preferred by many patients, its effectiveness ...
Cached Medicine News:Health News:Researchers Spot Genes Behind Macular Degeneration 2Health News:Combined inhibition of VEGF and c-MET can decrease metastasis 2Health News:Characteristics of fathers with depressive symptoms 2Health News:Characteristics of fathers with depressive symptoms 3Health News:Mobile DNA elements can disrupt gene expression and cause biological variation, study shows 2Health News:Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer 2Health News:Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer 3
... To complement the original ... Curved Scissors, but for cutting ... to the retina); curved tips ... close to the retlna. Tip ...
Sharp tipped scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and all purpose...
Claes Shielded Retinotomy Scissors, Curved Vertical...
... Focus Diagnostics Rickettsia Indirect Immunofluorescence ... intended for the detection and ... antibodies to Spotted Fever and ... an in vitro aid in ...
Medicine Products: